Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

169 Results
Title Activity Code Posting Date Expiration Date Sort descending
Maternal Health Research Centers of Excellence Implementation Science Hub/Resource Center (U24 Clinical Trial Optional) - RFA-HD-23-037 U24 August 11, 2022 December 06, 2022
Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional) - RFA-HD-23-035 U54 August 11, 2022 December 06, 2022
Maternal Health Research Centers of Excellence Data Innovation and Coordinating Hub/Resource Center (U24 Clinical Trial Not Allowed) - RFA-HD-23-036 U24 August 11, 2022 December 06, 2022
Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-050 R01 June 27, 2022 December 08, 2022
Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)- NOT-AI-20-005 R01, R15, R41/R42, R43/R44 November 12, 2019 January 08, 2023
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)- PAR-20-063 R24 November 22, 2019 January 08, 2023
Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics- NOT-AI-20-013 R01, R21, R41/R42, R43/R44 December 17, 2019 January 08, 2023
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)- PAR-20-210 K99/R00 May 14, 2020 January 08, 2023
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)- PAR-20-209 K99/R00 May 14, 2020 January 08, 2023
Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)- PAR-20-258 K01 August 24, 2020 January 08, 2023
Notice of Special Interest (NOSI)—Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals To Inform Innovative Tuberculosis Vaccine Design- NOT-AI-20-071 R01, R21 September 10, 2020 January 08, 2023
Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006 R01 December 21, 2021 January 08, 2023
Point-of-Care Technologies Research Network—Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional)- PAR-22-203 U54 July 13, 2022 January 08, 2023
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-20-139 R01 March 13, 2020 January 14, 2023
Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed)- RFA-AI-22-055 U01 August 22, 2022 January 14, 2023
Notice of Special Interest (NOSI)—Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional)- NOT-OD-22-030 Supp December 02, 2021 January 27, 2023
Notice of Special Interest (NOSI)—Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-208 Supp September 07, 2022 February 01, 2023
Notice of Special Interest (NOSI)— Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)- NOT-OD-22-031 Supp December 02, 2021 February 01, 2023
Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)- RFA-AI-22-059 UM1 September 21, 2022 February 08, 2023
Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)- RFA-AI-22-068 R21/R33 October 03, 2022 February 15, 2023
Genetic Tools for Understanding Rickettsial and Related Infections (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-047 R61/R33 October 03, 2022 February 15, 2023
Immunity in Older Adults (U01 Clinical Trial Not Allowed)- RFA-AI-22-060 U01 October 04, 2022 February 15, 2023
Notice of Special Interest (NOSI)—Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) - NOT-OD-23-018 Supp November 17, 2022 February 17, 2023
Notice of Special Interest (NOSI)—Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship- NOT-OD-23-002 Supp November 18, 2022 February 18, 2023
Notice of Special Interest (NOSI)—Research on Gender Measurement (Admin Supp Clinical Trial Optional)- NOT-OD-23-029 Supp December 05, 2022 March 01, 2023